Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma
Allison R. Hanaford(Johns Hopkins Medicine), Eric H. Raabe(Johns Hopkins University), Sabrina Wang(Johns Hopkins Medicine), Allison Martin(Albert Einstein College of Medicine), Jesse Alt(Johns Hopkins University), Harpreet Kaur(Johns Hopkins University), Daniel L.J. Thorek(Barnes-Jewish Hospital), Charles G. Eberhart(Johns Hopkins University), Rana Rais(Johns Hopkins University), Barbara S. Slusher(Johns Hopkins University)
Cited by 74
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging
|Annals of Biomedical Engineering|2006|772
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711